Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc E Lippman

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|June 5, 2018
Endocrine Adjuvant Therapy for Localized Breast CancerMarc E Lippman
British Journal of Cancer|November 1, 2022
Comment on "The lingering mysteries of metastatic recurrence in breast cancer"Barry I Hudson, Marc E Lippman
Journal of the American College of Cardiology|February 15, 2020
Adverse Cardiovascular Events in Cancer Trials: Missing in Action?Nanette H Bishopric, Marc E Lippman
Annual Review of Medicine|November 7, 2017
Targeting RAGE Signaling in Inflammatory DiseaseBarry I Hudson, Marc E Lippman
Breast Cancer Research and Treatment|March 5, 2004
Evaluation of novel epidermal growth factor receptor tyrosine kinase inhibitorsJames M Rae, Marc E Lippman
The Journal of Clinical Investigation|December 15, 2021
The role of estrogen receptor signaling in suppressing the immune response to cancerJames M Rae, Marc E Lippman
Seminars in Oncology|November 13, 2003
Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonistsShaomeng Wang, Dajun Yang, Marc E Lippman
Breast Cancer Research and Treatment|June 15, 2006
New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARKDaniel F Hayes, Stephen Ethier, Marc E Lippman
Breast Cancer Research and Treatment|May 19, 2009
Editorial: Cost-effective analyses in Breast Cancer Research and Treatment [corrected]Marc E Lippman, Stephen Ethier, Daniel F Hayes
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Liquid biopsy: expanding the frontier of circulating biomarker discovery and validation in breast cancerPhilip C Miller, Dorraya El-Ashry, Marc E Lippman
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|June 5, 2018
Endocrine Adjuvant Therapy for Localized Breast CancerMarc E Lippman
British Journal of Cancer|November 1, 2022
Comment on "The lingering mysteries of metastatic recurrence in breast cancer"Barry I Hudson, Marc E Lippman
Journal of the American College of Cardiology|February 15, 2020
Adverse Cardiovascular Events in Cancer Trials: Missing in Action?Nanette H Bishopric, Marc E Lippman
Annual Review of Medicine|November 7, 2017
Targeting RAGE Signaling in Inflammatory DiseaseBarry I Hudson, Marc E Lippman
Breast Cancer Research and Treatment|March 5, 2004
Evaluation of novel epidermal growth factor receptor tyrosine kinase inhibitorsJames M Rae, Marc E Lippman
The Journal of Clinical Investigation|December 15, 2021
The role of estrogen receptor signaling in suppressing the immune response to cancerJames M Rae, Marc E Lippman
Seminars in Oncology|November 13, 2003
Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonistsShaomeng Wang, Dajun Yang, Marc E Lippman
Breast Cancer Research and Treatment|June 15, 2006
New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARKDaniel F Hayes, Stephen Ethier, Marc E Lippman
Breast Cancer Research and Treatment|May 19, 2009
Editorial: Cost-effective analyses in Breast Cancer Research and Treatment [corrected]Marc E Lippman, Stephen Ethier, Daniel F Hayes
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Liquid biopsy: expanding the frontier of circulating biomarker discovery and validation in breast cancerPhilip C Miller, Dorraya El-Ashry, Marc E Lippman
Pageof 6